Related Experiment Video
Updated: Feb 24, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma
Richard J Lin1, Madhusmita Behera2, Catherine S Diefenbach3
1Memorial Sloan Kettering Cancer Center, New York, NY.
Abstract:
Survival outcome for elderly patients with newly diagnosed diffuse large B-cell lymphoma remains suboptimal in the rituximab era. In this systematic review, we summarize available evidence relevant to the inclusion of anthracycline in upfront chemoimmunotherapy for these elderly patients and highlight the need of prospective clinical trials. With limited prospective data, we find that pretreatment comprehensive geriatric assessment accurately predicts survival and treatment-related toxicities, suggesting its potential role in guiding overall treatment decision-making.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

